Rhythm Pharmaceuticals, Inc. (RYTM)

NASDAQ: RYTM · Real-Time Price · USD

90.64

+3.43 (3.93%)

At close: May 20, 2026, 4:00 PM EDT

92.99

+2.35 (2.59%)

After-hours: May 20, 2026, 4:49 PM EDT

Rhythm Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-202.68	-196.54	-260.6	-184.68	-181.12	-69.61
Depreciation & Amortization	1.21	1.34	1.56	1.76	1.67	1.16
Stock-Based Compensation	77.06	66.82	39.68	32.55	19.83	20.8
Other Adjustments	14.45	13.68	94.9	9.4	3.6	-100.25
Change in Receivables	-16.37	-7.57	-3.65	-8.64	-5.2	-1.25
Changes in Inventories	-9.99	-7.47	-10.12	-5.71	-2.81	-0.01
Changes in Accounts Payable	19.91	21.89	21.92	14.77	1.54	18.31
Changes in Unearned Revenue	0.05	-1.09	-	-0.15	-6.61	-
Changes in Other Operating Activities	-3.67	-6.72	2.42	4.53	-4.34	-15.15
Operating Cash Flow	-119.51	-115.68	-113.88	-136.16	-173.43	-146
Capital Expenditures	-	-0.95	-	-0.05	-0.28	-0.43
Purchases of Intangible Assets	-40	-40	-40.5	-5.67	-4	-5
Purchases of Investments	-357.35	-348.67	-268.31	-354.92	-251.94	-524.97
Proceeds from Sale of Investments	293.39	252.47	260.64	354.97	284.25	361.25
Other Investing Activities	-	-	-	-	-	107
Investing Cash Flow	-104.91	-137.15	-48.17	-5.67	28.03	-62.16
Long-Term Debt Issued	-	-	-	24.37	72.34	-
Long-Term Debt Repaid	-19.59	-19.92	-12.9	-7.4	-	-
Net Long-Term Debt Issued (Repaid)	-19.59	-19.92	-12.9	16.97	72.34	-
Issuance of Common Stock	-135.17	237.88	56.39	57.4	141.49	166.48
Repurchase of Common Stock	-8.46	-	-	-	-	-
Net Common Stock Issued (Repurchased)	-143.62	237.88	56.39	57.4	141.49	166.48
Issuance of Preferred Stock	-	-	138.85	-	-	-
Net Preferred Stock Issued (Repurchased)	-	-	138.85	-	-	-
Other Financing Activities	-	-	8.9	-	-	-
Financing Cash Flow	180.06	217.96	191.24	74.37	213.83	166.48
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.54	0.09	0	-0.14	-	-
Net Cash Flow	-43.82	-34.78	29.19	-67.6	68.43	-41.68
Free Cash Flow	-119.51	-116.63	-113.88	-136.2	-173.71	-146.44
FCF Margin	-55.03%	-61.46%	-87.51%	-175.91%	-734.87%	-4642.90%
Free Cash Flow Per Share	-1.81	-1.79	-1.87	-2.36	-3.33	-2.95
Levered Free Cash Flow	-219.93	-214.85	-261.69	-152.55	-119.6	-65.74
Unlevered Free Cash Flow	-190.81	-185.52	-250.07	-169.76	-189.98	-166.19

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q